长期幸存者不可切除的胰腺癌治疗与同时化学放射治疗
1Department of Gastroenterology, Dankook University Hospital, Dankook University College of Medicine, Cheonan, Korea.
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
|January 25, 2024
概括
本案例研究表明,一种罕见的胰腺不分化癌 (UPC) 对化疗和化疗放射治疗反应良好. 非手术治疗导致显著的瘤缩和晚期胰腺癌的长期存活.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 胰腺不分化癌 (UPC) 是一种罕见且具有攻击性的恶性瘤.
- 患者经常出现无法切除的疾病,需要探索非手术治疗选择.
研究的目的:
- 报告一种局部发达的,无法切除的UPC病例,具有骨质细胞类巨细胞.
- 评估对非手术治疗的长期反应,包括化疗和化疗放射治疗.
主要方法:
- 一名40岁的男性被诊断患有6厘米不可切割的胰腺质量,接受了修改后的FOLFIRINOX化疗.
- 同时进行化学放射治疗.
- 在六年内使用成像 (FDG-PET/CT) 评估瘤反应.
主要成果:
- 患者实现了显著的瘤缩小,从6厘米缩小到3.5厘米.
- FDG-PET/CT表明残留瘤中没有代谢活性.
- 尽管该患者患有不可切除的疾病并停止治疗,但患者的生存期为6年.
结论:
- 包括化疗和化疗放射治疗在内的非手术治疗可以导致不可切除的UPC显著的长期反应.
- 这一案例凸显了晚期胰腺癌潜在的新疗法.
- 需要进一步的综合性研究来验证这些发现.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
12:07Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
Published on: November 18, 2022
3.8K
相关概念视频
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
01:29Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92